Search results
Study finds AI tool opens data visualization to more students
Phys.org· 5 days agoA new study from the Tepper School of Business at Carnegie Mellon University published in the...
Decoding Verisk Analytics Inc (VRSK): A Strategic SWOT Insight
Guru Focus· 3 days agoVerisk Analytics Inc (VRSK, Financial), a leading provider of statistical, actuarial, and underwriting data, has recently filed its 10-Q report on May 1 ...
JD Supra: EEOC Releases EEO-1 Component 2 Pay Data Dashboard Site
JD Supra· 5 hours agoOver four years after collecting pay data from approximately 70,000 private employers and federal contractors via its controversial EEO-1 “Component 2” form, EEOC has released ...
6 ways to use AI for paid search account restructuring
Search Engine Land· 3 days agoSurface statistically significant opportunities: Some search terms need more data before they are...
The Case of the AI-Generated Giant Rat Penis
Reason.com via AOL· 14 hours agoAnother, on lithium battery technology, opens with the standard helpful AI locution...there are the "tortured phrases" that strongly suggest a paper has...
Potential unleashed: How companies can leverage new technologies for safe data sharing
Fortune via Yahoo Finance· 2 days agoThe rise of AI-generated, synthetic data is also reducing the risks associated with handling...
A Digital Approach to Tackling Equity in Tacoma, Wash.
Government Technology· 4 days agoTacoma, Wash., Mayor Victoria Woodards completed her term as president of the National League of...
Verisk Analytics Inc (VRSK) Q1 2024 Earnings: Solid Performance
Guru Focus· 3 days agoRevenue: Reported at $704 million, marking an 8.0% increase year-over-year, surpassing the estimated $699.06 million.Net Income: Achieved $219 million from con
Google Sheets Vs. Microsoft Excel—Which Is Better?
Forbes· 4 days agoCall them Google Sheets, Excel spreadsheets, or Zoho Sheets, but whatever app you use, they are a legacy tool that form an integral part of our...
Johnson & Johnson-Partnered Addex Therapeutics' Epilepsy Candidate Fails Mid-Stage Study, Stock...
Benzinga via AOL· 5 days agoMonday, Addex Therapeutics (NASDAQ:ADXN) released top-line data from a Phase 2 epilepsy study...
